TYRA
Price
$12.52
Change
+$0.05 (+0.40%)
Updated
Sep 12 closing price
Capitalization
667.28M
47 days until earnings call
XENE
Price
$36.21
Change
-$1.01 (-2.71%)
Updated
Sep 12 closing price
Capitalization
2.87B
53 days until earnings call
Interact to see
Advertisement

TYRA vs XENE

Header iconTYRA vs XENE Comparison
Open Charts TYRA vs XENEBanner chart's image
Tyra Biosciences
Price$12.52
Change+$0.05 (+0.40%)
Volume$196.34K
Capitalization667.28M
Xenon Pharmaceuticals
Price$36.21
Change-$1.01 (-2.71%)
Volume$562.31K
Capitalization2.87B
TYRA vs XENE Comparison Chart in %
Loading...
TYRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XENE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
TYRA vs. XENE commentary
Sep 13, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TYRA is a Hold and XENE is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 13, 2025
Stock price -- (TYRA: $12.52 vs. XENE: $36.21)
Brand notoriety: TYRA and XENE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: TYRA: 90% vs. XENE: 66%
Market capitalization -- TYRA: $667.28M vs. XENE: $2.87B
TYRA [@Biotechnology] is valued at $667.28M. XENE’s [@Biotechnology] market capitalization is $2.87B. The market cap for tickers in the [@Biotechnology] industry ranges from $101.15B to $0. The average market capitalization across the [@Biotechnology] industry is $1.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

TYRA’s FA Score shows that 1 FA rating(s) are green whileXENE’s FA Score has 1 green FA rating(s).

  • TYRA’s FA Score: 1 green, 4 red.
  • XENE’s FA Score: 1 green, 4 red.
According to our system of comparison, XENE is a better buy in the long-term than TYRA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

TYRA’s TA Score shows that 5 TA indicator(s) are bullish while XENE’s TA Score has 5 bullish TA indicator(s).

  • TYRA’s TA Score: 5 bullish, 4 bearish.
  • XENE’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, both TYRA and XENE are a good buy in the short-term.

Price Growth

TYRA (@Biotechnology) experienced а -1.03% price change this week, while XENE (@Biotechnology) price change was -7.65% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.38%. For the same industry, the average monthly price growth was +7.84%, and the average quarterly price growth was +35.14%.

Reported Earning Dates

TYRA is expected to report earnings on Oct 30, 2025.

XENE is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+1.38% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
XENE($2.87B) has a higher market cap than TYRA($667M). XENE YTD gains are higher at: -7.628 vs. TYRA (-9.928). TYRA has higher annual earnings (EBITDA): -121.07M vs. XENE (-315.5M). XENE has more cash in the bank: 488M vs. TYRA (296M). TYRA has less debt than XENE: TYRA (6.02M) vs XENE (8.72M). XENE has higher revenues than TYRA: XENE (7.5M) vs TYRA (0).
TYRAXENETYRA / XENE
Capitalization667M2.87B23%
EBITDA-121.07M-315.5M38%
Gain YTD-9.928-7.628130%
P/E RatioN/AN/A-
Revenue07.5M-
Total Cash296M488M61%
Total Debt6.02M8.72M69%
FUNDAMENTALS RATINGS
XENE: Fundamental Ratings
XENE
OUTLOOK RATING
1..100
76
VALUATION
overvalued / fair valued / undervalued
1..100
50
Fair valued
PROFIT vs RISK RATING
1..100
40
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
50
P/E GROWTH RATING
1..100
6
SEASONALITY SCORE
1..100
65

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
TYRAXENE
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
75%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
79%
Momentum
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
85%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
75%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
76%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
75%
Advances
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 12 days ago
72%
Declines
ODDS (%)
Bearish Trend 5 days ago
87%
Bearish Trend 4 days ago
71%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
TYRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XENE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RYMAX56.36N/A
N/A
Rydex Telecommunications H
TRVHX19.15N/A
N/A
Nuveen Mid Cap Value I
ALGAX22.56N/A
N/A
Alger International Opportunities A
OTCNX82.54N/A
N/A
Invesco Discovery Large Cap R
MIPIX16.87N/A
N/A
Matthews Asia Dividend Instl

TYRA and

Correlation & Price change

A.I.dvisor indicates that over the last year, TYRA has been loosely correlated with NRIX. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if TYRA jumps, then NRIX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TYRA
1D Price
Change %
TYRA100%
+0.40%
NRIX - TYRA
45%
Loosely correlated
-1.74%
AURA - TYRA
42%
Loosely correlated
-6.93%
DYN - TYRA
42%
Loosely correlated
-0.19%
RGNX - TYRA
40%
Loosely correlated
-3.06%
XENE - TYRA
40%
Loosely correlated
-2.71%
More